Loading Icon

Fas ligand

Fas ligand (FasL or CD95L or CD178) is a type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. Its binding with its receptor induces apoptosis. Fas ligand/receptor interactions play an important role in the regulation of the immune system and the progression of cancer.
More from Wikipedia

Metrics Summary

Total Publications
Lifetime
2,742
Prior Five Years
134
Total Citations
Lifetime
98,134
Prior Five Years
824
Total Scholars
Lifetime
8,582
Prior Five Years
6,150

Institutional Rankings

Global (Worldwide)
Academic Institutions
Lifetime		 Academic Institutions
Prior Five Years		 Non-academic Institutions
Lifetime
#1
Juntendo University
Japan
#1
University of Tennessee Health Science Center
United States
#1
St. Jude Children's Research Hospital
United States
#2
Osaka University
Japan
#2
Université de Paris
France
#2
Genentech, Inc.
United States
#3
University College Cork
Ireland
#3
Mercy
United States
#4
Yale University
United States
#4
Novartis International AG
Switzerland
#5
University of Washington
United States
#5
National Cancer Institute, National Institutes of Health
United States
#6
Kanazawa University
Japan
#6
AstraZeneca plc
United States
#7
University of Konstanz
Germany
Show More
#8
University of Lausanne
Switzerland
#9
Washington University in St. Louis
United States
#10
Tokushima University
Japan
Show More
Show More
National Institutional Rankings

Publications and Citation History

Publications based on Disciplines

Scholars based on Disciplines

Publications based on Fields

Scholars based on Fields

Highly Ranked Scholars™

Lifetime
Prior Five Years

Highly Cited Publications

Lifetime